Results 261 to 270 of about 344,963 (356)

Anti‐ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune‐Mediated TTP

American Journal of Hematology, EarlyView.
Anti‐ADAMTS13 IgG antibodies titer trajectory from baseline to day 7–14 post‐TPE as a reliable approach to identify iTTP patients at risk of late response to the triplet therapy regimen. ABSTRACT Current triplet regimens associating therapeutic plasma exchange (TPE), immunosuppression with corticosteroids and rituximab, and caplacizumab have ...
Marie Robert, Arthur Mageau, Ygal Benhamou, François Provôt, Jehane Fadlallah, Lionel Galicier, Elie Azoulay, Hafid Ait‐Oufella, Tomas Urbina, Pascale Poullin, Alain Wynckel, Coralie Poulain, Nihal Martis, Pierre Perez, Virginie Rieu, Yahsou Delmas, Jean‐Michel Halimi, Christelle Barbet, Amélie Seguin, Valérie Chatelet, Jean‐François Augusto, Mathieu Legendre, Olivier Moranne, Carole Philipponnet, Bérengère Cador, Raïda Bouzid, Bérangère S. Joly, Agnès Veyradier, Paul Coppo, on behalf of the French Reference Center for Thrombotic Microangiopathies   +29 more
wiley   +1 more source

Positive association between serum lactate dehydrogenase levels and blood pressure: evidence from NHANES 2015-2016. [PDF]

Front Cardiovasc Med
Hu T, Li L, Cao Q, Tu W, Huang X, Yuan T.   +5 more
europepmc   +1 more source

Use of latex microbeads for detection of Plasmodium vivax lactate dehydrogenase using flow cytometry. [PDF]

Braz J Med Biol Res
Franco AMF, Glória JC, Chaves YO, Ferreira AS, Teles CBG, Balieiro AAS, Neves WLL, Sousa LP, Costa JDN, Nogueira PA, Mariúba LAM.   +10 more
europepmc   +1 more source

Lactate and Malate Dehydrogenase Isozyme Patterns in Fish and Marine Mammals

, 1970
Ken-ichi Numachi
openalex   +2 more sources

Effect of early initation of Eculizumab in patients with aHUS on renal outcomes: a pooled analysis [PDF]

, 2016
Ardissimo, Gianluigi, Cataland, Spero R, Delmas, Yahsou, Kincaid, John F, Vande Walle, Johan, Wang, Jimmy   +5 more
core  

Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience

American Journal of Hematology, EarlyView.
ABSTRACT Breakthrough hemolysis (BTH) is defined as a hemolytic exacerbation in a patient with paroxysmal nocturnal hemoglobinuria (PNH) treated with complement inhibitors (CIs). In the current era of several terminal and proximal inhibitors, there are no guidelines for defining BTH and its severity, and clinical management is not standardized.
Bruno Fattizzo, Giacinto Luca Pedone, Elisabetta Metafuni, Eloise Beggiato, Valentina Giai, Esther Natalie Oliva, Antony Ricchiuti, Marta Bortolotti, Simona Raso, Daniela Carlino, Mara Memoli, Sofia Vecchi, Jennifer Vidler, Sukanya Gogoi, Shreya Goel, Anna Corby, Roochi Trikha, Sneha Balakrishnan, Francesco Passamonti, Anna Paola Iori, Simona Sica, Shreyans Gandhi, Wilma Barcellini, Austin Kulasekararaj   +23 more
wiley   +1 more source

Antepartum Serum Lactate Dehydrogenase and Adverse Obstetric Outcomes in Preeclampsia: A Systematic Review of Prognostic Evidence From Low- and Middle-Income Countries. [PDF]

Cureus
Nguyen KD, Tn Khuc A, A Tran V, S Nguyen H, H Nguyen P, Th Nguyen A.   +5 more
europepmc   +1 more source

Structure of the flavin adduct formed in the suicide reaction of .alpha.-hydroxybutynoate with D-lactate dehydrogenase

, 1979
Sandro Ghisla, Steven T. Olson, Vincent Massey, Jean‐Marc Lhoste   +3 more
openalex   +2 more sources